The Shanghai, China-based biotechnology company cited market conditions and the trading price for its American depositary shares as reasons for the postponement.
WuXi PharmaTech shares rose 3.2% to $19.30 on volume of 81,500. Greg Saulnier gs/jw
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
MMMM
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
|


